Ligne de temps

Atousa Arbabian
Post-doctorant(e)
21 nov. 2025
publication
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo.
Lire plus10 oct. 2025
21 juin 2024
publication
Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus.
Lire plus08 févr. 2019
11 mai 2015